Share

Clinical Studies (1)

  • Raguž : Study aims to determine the specific characteristics of children immunised with palivizumab during a 15-year period and the readmissions to hospital due to potential infections of the respiratory tract

Study Data

  • Infants (<1 year)
  • Fragile population
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection
  • Pharmacological intervention
  • Monoclonal antibodies
  • Palivizumab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to